🔴 Novanta is trading 4.7% down today following the Fed's rate hike and hawkish outlook

Novanta is trading 4.7% down at $131.68 as broader equity weakness intensified following the Federal Reserve’s September 16, 2026 rate hike and hawkish outlook.

• No clear company-specific announcement has been identified to explain the decline.
• The latest identified company event was a September 15 presentation at the Baird Global Healthcare Conference.
• A director’s September 11 share sale was reported but does not clearly explain today’s move.